VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Financial Statements
IMP: Financial Statement Q4. 2022
11/13/2013
IMP - FINANCIAL STATEMENTS FOR THE YEAR END 31 DECEMBER 2023 (has been audited)
03/27/2024
IMP: Financial Statement Q3. 2023
10/18/2023
IMP: Financial Statement Q2. 2023
07/18/2023
IMP: Financial Statement Q1. 2023
04/18/2023
IMP: Imexpharm Corporation Financial Statements for The Year Ended 31 December 2022
03/24/2023